Variant report

Variant	nsv886951
Chromosome Location	chr6:167786021-167832771
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:389)
CpG islands
(count:1955)
Chromatin interactive
region (count:8)
LncRNA
region (count:10)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:389 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:167809998-167810531	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:167811767-167812223	HepG2	liver:	n/a	n/a
3	BATF	chr6:167801477-167801674	GM12878	blood:	n/a	n/a
4	BCL11A	chr6:167801917-167802109	GM12878	blood:	n/a	n/a
5	BCL11A	chr6:167801472-167801775	GM12878	blood:	n/a	n/a
6	BCL11A	chr6:167801474-167801790	GM12878	blood:	n/a	n/a
7	BCL11A	chr6:167799353-167799569	GM12878	blood:	n/a	n/a
8	BCL11A	chr6:167800632-167800815	GM12878	blood:	n/a	n/a
9	BHLHE40	chr6:167811648-167812302	HepG2	liver:	n/a	n/a
10	BHLHE40	chr6:167827209-167827450	K562	blood:	n/a	n/a
11	BHLHE40	chr6:167826030-167826420	HepG2	liver:	n/a	n/a
12	BHLHE40	chr6:167810045-167810579	HepG2	liver:	n/a	n/a
13	BHLHE40	chr6:167815066-167815240	K562	blood:	n/a	chr6:167815146-167815155 chr6:167815144-167815157 chr6:167815147-167815156 chr6:167815140-167815161 chr6:167815146-167815155
14	BHLHE40	chr6:167814832-167815507	HepG2	liver:	n/a	chr6:167815146-167815155 chr6:167815144-167815157 chr6:167815147-167815156 chr6:167815140-167815161 chr6:167815146-167815155
15	BHLHE40	chr6:167811642-167812135	HepG2	liver:	n/a	n/a
16	BRCA1	chr6:167811846-167812095	HepG2	liver:	n/a	n/a
17	CBX3	chr6:167800537-167800803	K562	blood:	n/a	n/a
18	CEBPB	chr6:167811682-167811930	HepG2	liver:	n/a	n/a
19	CEBPB	chr6:167811663-167812136	HepG2	liver:	n/a	n/a
20	CEBPB	chr6:167823739-167824431	HepG2	liver:	n/a	chr6:167824329-167824338 chr6:167824327-167824340
21	CEBPB	chr6:167830864-167831090	HepG2	liver:	n/a	chr6:167831007-167831018
22	CEBPB	chr6:167810129-167810428	HepG2	liver:	n/a	n/a
23	CHD1	chr6:167807154-167807163	GM12878	blood:	n/a	n/a
24	CHD2	chr6:167815273-167815334	HepG2	liver:	n/a	n/a
25	CHD2	chr6:167812114-167812170	HepG2	liver:	n/a	n/a
26	CHD2	chr6:167811596-167811760	HepG2	liver:	n/a	n/a
27	CTCF	chr6:167789420-167789570	HEK293	kidney:	n/a	n/a
28	CTCF	chr6:167786760-167786910	GM12872	blood:	n/a	n/a
29	CTCF	chr6:167789460-167789610	BE2_C	brain:	n/a	n/a
30	CTCF	chr6:167789340-167789490	HA-sp	spinal cord:	n/a	n/a
31	CTCF	chr6:167819300-167819450	GM12869	blood:	n/a	n/a
32	CTCF	chr6:167821160-167821310	HepG2	liver:	n/a	n/a
33	CTCF	chr6:167789357-167789577	H1-hESC	embryonic stem cell:	n/a	n/a
34	CTCF	chr6:167789400-167789550	HepG2	liver:	n/a	n/a
35	CTCF	chr6:167803421-167803496	GM10248	blood:	n/a	n/a
36	CTCF	chr6:167806024-167806089	Kidney_OC	kidney:	n/a	n/a
37	CTCF	chr6:167814940-167815090	Caco-2	colon:	n/a	n/a
38	CTCF	chr6:167816369-167816416	GM20000	blood:	n/a	n/a
39	CTCF	chr6:167802765-167802797	Lung_OC	lung:	n/a	n/a
40	CTCF	chr6:167789400-167789550	Caco-2	colon:	n/a	n/a
41	CTCF	chr6:167815000-167815150	HepG2	liver:	n/a	n/a
42	CTCF	chr6:167810500-167810650	HepG2	liver:	n/a	n/a
43	CTCF	chr6:167786102-167786104	HUVEC	blood vessel:	n/a	n/a
44	CTCF	chr6:167789420-167789570	WERI-Rb-1	eye:	n/a	n/a
45	CTCF	chr6:167815300-167815450	HepG2	liver:	n/a	n/a
46	CTCF	chr6:167786153-167786230	Medullo	brain:	n/a	n/a
47	CTCF	chr6:167789339-167789607	H1-hESC	embryonic stem cell:	n/a	n/a
48	CTCF	chr6:167786092-167786101	HUVEC	blood vessel:	n/a	n/a
49	CTCF	chr6:167815420-167815570	BE2_C	brain:	n/a	n/a
50	CTCF	chr6:167789460-167789610	HEK293	kidney:	n/a	n/a

(count:1955 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:167803413-167803463	SK-N-MC	brain:	n/a
2	chr6:167813267-167813317	PrEC	prostate:	n/a
3	chr6:167814397-167814447	HAEpiC	amniotic membrane:	n/a
4	chr6:167803413-167803463	SK-N-MC	brain:	n/a
5	chr6:167813267-167813317	PrEC	prostate:	n/a
6	chr6:167814397-167814447	HAEpiC	amniotic membrane:	n/a
7	chr6:167789195-167789245	ECC-1	luminal epithelium:	n/a
8	chr6:167786642-167786692	LNCaP	prostate:	n/a
9	chr6:167814314-167814364	SK-N-SH	brain:	n/a
10	chr6:167791114-167791164	IMR90	lung:	fetal
11	chr6:167794374-167794424	ovcar-3	ovarian:	n/a
12	chr6:167791153-167791203	HRCEpiC	kidney:	n/a
13	chr6:167798410-167798460	CMK	blood:	n/a
14	chr6:167832664-167832714	HCF	heart:	n/a
15	chr6:167809825-167809875	HMEC	breast:	n/a
16	chr6:167791024-167791074	SK-N-MC	brain:	n/a
17	chr6:167814314-167814364	Hela-S3	cervix:	n/a
18	chr6:167832664-167832714	NHDF-neo	bronchial:	n/a
19	chr6:167792741-167792791	PrEC	prostate:	n/a
20	chr6:167813372-167813422	HCT-116	colon:	n/a
21	chr6:167786592-167786642	CMK	blood:	n/a
22	chr6:167803413-167803463	HMEC	breast:	n/a
23	chr6:167786592-167786642	AG04450	lung:	fetal
24	chr6:167791114-167791164	RPTEC	kidney:	n/a
25	chr6:167794506-167794556	CMK	blood:	n/a
26	chr6:167808551-167808601	CMK	blood:	n/a
27	chr6:167814397-167814447	Hela-S3	cervix:	n/a
28	chr6:167809876-167809926	GM19239	blood:	n/a
29	chr6:167797877-167797927	A549	lung:	n/a
30	chr6:167808366-167808416	SK-N-SH	brain:	n/a
31	chr6:167792741-167792791	Caco-2	colon:	n/a
32	chr6:167810395-167810445	NH-A	brain:	n/a
33	chr6:167814257-167814307	HPAEpiC	pulmonary alveolar:	n/a
34	chr6:167810043-167810093	HRCEpiC	kidney:	n/a
35	chr6:167810343-167810393	HCF	heart:	n/a
36	chr6:167786642-167786692	AoSMC	blood vessel:	n/a
37	chr6:167794374-167794424	NH-A	brain:	n/a
38	chr6:167813267-167813317	AG09309	skin:	n/a
39	chr6:167786592-167786642	AoSMC	blood vessel:	n/a
40	chr6:167786642-167786692	HUVEC	blood vessel:	n/a
41	chr6:167792181-167792231	HNPCEpiC	eye:	n/a
42	chr6:167814257-167814307	HIPEpiC	eye:	n/a
43	chr6:167792181-167792231	BJ	skin:	n/a
44	chr6:167791114-167791164	NB4	blood:	n/a
45	chr6:167814257-167814307	IMR90	lung:	fetal
46	chr6:167808366-167808416	AG09309	skin:	n/a
47	chr6:167809972-167810022	AG09319	gingival:	n/a
48	chr6:167809825-167809875	H1-hESC	embryonic stem cell:	embryo
49	chr6:167798410-167798460	HepG2	liver:	n/a
50	chr6:167808366-167808416	PANC-1	pancreas:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:167813417..167815135-chr6:167817698..167819518,2	K562	blood:
2	chr6:167818746..167821496-chr6:167831177..167833070,2	K562	blood:
3	chr6:167818746..167821496-chr6:167831177..167833070,2	K562	blood:
4	chr6:167823826..167826272-chr6:167829672..167831832,2	K562	blood:
5	chr20:57615578..57617834-chr6:167831422..167833295,2	MCF-7	breast:
6	chr6:167813417..167815135-chr6:167817698..167819518,2	K562	blood:
7	chr6:167662732..167663315-chr6:167819023..167819880,2	K562	blood:
8	chr6:167823826..167826272-chr6:167829672..167831832,2	K562	blood:

(count:10 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TCP10-3	chr6:167826637-167827774	ucscGeneNc_uc003qvy_1
2	lnc-TCP10-1	chr6:167786578-167786848	NONHSAT116097
3	lnc-TCP10-2	chr6:167822441-167822752	ucscGeneNc_uc003qvx_1
4	lnc-TCP10-3	chr6:167823155-167825466	ucscGeneNc_uc003qvy_1
5	lnc-TTLL2-1	chr6:167804760-167804979	XLOC_005541
6	lnc-TCP10-3	chr6:167825862-167825976	ucscGeneNc_uc003qvy_1
7	lnc-TCP10-2	chr6:167810373-167814438	ucscGeneNc_uc003qvx_1
8	lnc-TCP10-2	chr6:167821589-167821728	ucscGeneNc_uc003qvx_1
9	lnc-TTLL2-1	chr6:167803650-167803969	XLOC_005541
10	lnc-TCP10-1	chr6:167787839-167789289	NONHSAT116097

No data

Variant related genes	Relation type
TCP10	TF binding region
TCP10	CpG island
ENSG00000101166	chromatin interactions

Extended variants
information (count: 1966 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:1966 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6925680	chr6:167786021-167786022	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs189340409	chr6:167786030-167786031	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs202182298	chr6:167786059-167786060	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs569384016	chr6:167786084-167786085	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs539898152	chr6:167786121-167786122	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs558014180	chr6:167786130-167786131	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs566847382	chr6:167786133-167786134	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs3010583	chr6:167786212-167786213	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs533900372	chr6:167786216-167786217	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs555801674	chr6:167786233-167786234	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs574751579	chr6:167786258-167786259	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs143859472	chr6:167786310-167786311	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs542180929	chr6:167786316-167786317	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs201963969	chr6:167786424-167786425	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs557173190	chr6:167786445-167786446	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs575397290	chr6:167786485-167786486	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs545875773	chr6:167786550-167786551	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs146852129	chr6:167786551-167786552	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs528196448	chr6:167786563-167786564	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs3798324	chr6:167786574-167786575	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs375517388	chr6:167786593-167786594	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
22	rs539816886	chr6:167786614-167786615	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs369340315	chr6:167786623-167786624	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
24	rs529524933	chr6:167786627-167786628	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
25	rs372467539	chr6:167786642-167786643	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
26	rs62428279	chr6:167786643-167786644	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
27	rs370446616	chr6:167786651-167786652	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
28	rs181671268	chr6:167786673-167786674	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
29	rs377499408	chr6:167786681-167786682	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
30	rs140649985	chr6:167786686-167786687	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
31	rs375831091	chr6:167786687-167786688	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
32	rs201083342	chr6:167786689-167786690	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
33	rs146321515	chr6:167786690-167786691	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
34	rs367938179	chr6:167786692-167786693	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
35	rs555781659	chr6:167786700-167786701	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
36	rs567690005	chr6:167786703-167786704	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
37	rs200717360	chr6:167786714-167786715	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs372144507	chr6:167786727-167786728	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
39	rs143094588	chr6:167786750-167786751	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs78500930	chr6:167786757-167786758	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
41	rs200948850	chr6:167786761-167786762	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
42	rs575502722	chr6:167786765-167786766	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
43	rs371810273	chr6:167786783-167786784	Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
44	rs545630845	chr6:167786803-167786804	Enhancers Bivalent Enhancer Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
45	rs557950844	chr6:167786856-167786857	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs572819368	chr6:167786883-167786884	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs375849186	chr6:167786884-167786885	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs539976123	chr6:167786903-167786904	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs199709182	chr6:167786907-167786908	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs185908678	chr6:167786926-167786927	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:163 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:167785400-167786600	Weak transcription	Fetal Intestine Small	intestine
2	chr6:167785400-167786600	Weak transcription	HepG2	liver
3	chr6:167785800-167786200	Enhancers	Rectal Mucosa Donor 31	rectum
4	chr6:167786200-167786600	Weak transcription	Rectal Mucosa Donor 31	rectum
5	chr6:167786400-167786600	Enhancers	Fetal Intestine Large	intestine
6	chr6:167786400-167786600	Enhancers	Rectal Mucosa Donor 29	rectum
7	chr6:167786600-167787000	Enhancers	Liver	Liver
8	chr6:167786600-167787000	Enhancers	Duodenum Mucosa	Duodenum
9	chr6:167786600-167787000	Flanking Active TSS	Fetal Intestine Large	intestine
10	chr6:167786600-167787000	Flanking Active TSS	Fetal Intestine Small	intestine
11	chr6:167786600-167787000	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
12	chr6:167786600-167787000	Enhancers	Rectal Mucosa Donor 31	rectum
13	chr6:167786600-167787000	Enhancers	Stomach Mucosa	stomach
14	chr6:167786600-167787000	Flanking Active TSS	HepG2	liver
15	chr6:167786800-167787000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
16	chr6:167787000-167787400	Enhancers	Fetal Intestine Large	intestine
17	chr6:167787000-167787600	Enhancers	HepG2	liver
18	chr6:167787000-167788000	Enhancers	Fetal Intestine Small	intestine
19	chr6:167787600-167791200	Weak transcription	HepG2	liver
20	chr6:167791000-167791200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
21	chr6:167791200-167791400	Enhancers	HepG2	liver
22	chr6:167791400-167791600	Bivalent Enhancer	HepG2	liver
23	chr6:167796200-167796400	Bivalent Enhancer	HepG2	liver
24	chr6:167807200-167807400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr6:167807200-167807600	Enhancers	Rectal Smooth Muscle	rectum
26	chr6:167807400-167807600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr6:167807400-167809600	Bivalent Enhancer	HepG2	liver
28	chr6:167807600-167814400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr6:167808200-167808400	Enhancers	Fetal Lung	lung
30	chr6:167808400-167809000	Weak transcription	Fetal Lung	lung
31	chr6:167809000-167809800	Enhancers	Fetal Lung	lung
32	chr6:167809200-167812600	Enhancers	Liver	Liver
33	chr6:167809200-167812800	Enhancers	Fetal Intestine Small	intestine
34	chr6:167809400-167811800	Enhancers	Stomach Mucosa	stomach
35	chr6:167809400-167812800	Enhancers	Fetal Intestine Large	intestine
36	chr6:167809600-167810400	Flanking Bivalent TSS/Enh	HepG2	liver
37	chr6:167809800-167810400	Weak transcription	Fetal Lung	lung
38	chr6:167809800-167810400	Enhancers	Rectal Mucosa Donor 31	rectum
39	chr6:167810000-167810600	Enhancers	Pancreas	Pancrea
40	chr6:167810000-167811400	Enhancers	Gastric	stomach
41	chr6:167810400-167810600	Enhancers	Fetal Lung	lung
42	chr6:167810400-167810800	Flanking Active TSS	HepG2	liver
43	chr6:167810400-167811800	Enhancers	Spleen	Spleen
44	chr6:167810400-167814800	Weak transcription	Rectal Mucosa Donor 31	rectum
45	chr6:167810600-167811800	Weak transcription	Pancreas	Pancrea
46	chr6:167810800-167811600	Enhancers	HepG2	liver
47	chr6:167811000-167811800	Weak transcription	Lung	lung
48	chr6:167811200-167812200	Enhancers	Duodenum Mucosa	Duodenum
49	chr6:167811200-167812800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
50	chr6:167811600-167812400	Flanking Active TSS	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links